Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial Assessing the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity

NCT07791537 is registered in ClinicalTrials.gov with Shanghai Minwei Biotechnology Co., Ltd as lead sponsor.

NCT NCT07791537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07791537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial Assessing the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity
Lead sponsor
Shanghai Minwei Biotechnology Co., Ltd
Phase
Phase 2
Overall status
Active, not recruiting
Start date
December 26, 2025
Completion date
November 30, 2026
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overweight , obesity